循环素依赖性激酶11:细胞功能和潜在的治疗应用
Janhabee Shrestha1, Jason Blanchard1, Solomon Tadesse2
1Idaho State University, Biomedical and Pharmaceutical Sciences, UNITED STATES OF AMERICA.
ChemMedChem
|July 8, 2025
概括
循环素依赖激酶11 (CDK11) 对于基因转录和细胞分裂至关重要. 抑制CDK11可能为抗癌和其他疾病提供新的策略.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 循环素依赖酶11 (CDK11) 是一个关键酶,调节转录和RNA剪接.
- CDK11的功能包括促进转录延长,3'-end处理和染色体分离.
- 它通过激活spliceosome,对全球mRNA前拼接至关重要.
研究的目的:
- 提供CDK11的生物功能和调节的全面概述.
- 讨论CDK11在癌症,病毒和神经退行性疾病中的参与.
- 突出CDK11抑制剂的发展作为潜在的治疗方法.
主要方法:
- 关于CDK11在细胞过程中的作用的文献综述.
- 对CDK11在疾病发病过程中的参与进行分析.
- 关于CDK11抑制剂开发的当前研究的摘要.
主要成果:
- 抑制CDK11会破坏转录和细胞循环的进展.
- CDK11与癌症扩散,HIV-1复制和阿尔茨海默病病理学有关.
- OTS964是CDK11抑制剂的一个例子,可以促进理解和治疗前景.
结论:
- CDK11是基本细胞过程的关键调节者.
- CDK11的失调与人类重大疾病有关.
- 向CDK11是一个有前途的治疗策略,特别是在癌症中.
更多相关视频
11:11Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
7.5K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
相关概念视频
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
02:15M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
02:39Positive Regulator Molecules
5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K